• 放射線治療とは
  • 受診希望の方へ
  • 設備紹介
  • 患者様の声
  • 手術との成績比較
  • 研究・業績
  • スタッフ
  • 入局案内
ホーム  >  研究・業績  >  2009年

研究・業績

2009年の一覧

Stereotactic radiosurgery for skull base meningioma.

Igaki H, Maruyama K, Koga T, Murakami N, Tago M, Terahara A, Shin M, Nakagawa K, Ohtomo K.

Neurol Med Chir (Tokyo), 2009 Oct;49(10):456-61.
A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.

Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K.

J Surg Oncol, 2009 Nov 1;100(6):435-41.
Quality assurance of volumetric modulated arc therapy using Elekta Synergy.

Haga A, Nakagawa K, Shiraishi K, Itoh S, Terahara A, Yamashita H, Ohtomo K, Saegusa S, Imae T, Yoda K, Pellegrini R.

Acta Oncol, 2009 Jul 29:1-5. [Epub ahead of print]
First report on prostate displacements immediately before and after treatment relative to the position during VMAT delivery.

Nakagawa K, Shiraishi K, Kida S, Haga A, Yamamoto K, Saegusa S, Terahara A, Itoh S, Ohtomo K, Yoda K.

Acta Oncol, 2009 Jul 25:1-2. [Epub ahead of print] No abstract available.
Histological changes after single high-dose irradiation for squamous cell carcinoma arising from a burn scar.

Kan Y, Yamashita H, Le Pavoux A, Ushiku T, Ohtomo K, Nakagawa K.

Med Oncol, 2009 Feb 13. [Epub ahead of print]
Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.

Yamashita H, Murakami N, Asari T, Okuma K, Ohtomo K, Nakagawa K.

Int J Radiat Oncol Biol Phys, 2009 Jul 15;74(4):1165-72. Epub 2008 Dec 26.
Dose verification of intensity-modulated arc therapy using an ERGO++ treatment planning system and Elekta internal multileaf collimators for prostate cancer treatment.

Yoda K, Nakagawa K, Shiraishi K, Okano Y, Ohtomo K, Pellegrini RG.

Br J Radiol, 2009 Apr;82(976):328-31. Epub 2008 Dec 8.
Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patients.

Yamashita H, Nakagawa K, Asari T, Murakami N, Igaki H, Okuma K, Ohtomo K.

Dis Esophagus, 2009;22(2):113-8. Epub 2008 Oct 1.
Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.

Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, Asakage T, Nakao K, Ebihara Y, Ohtomo K, Nakagawa K.

Auris Nasus Larynx, 2009 Jun;36(3):310-3. Epub 2008 Jul 16.
Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer.

Yamashita H, Nakagawa K, Hosoi Y, Kurokawa A, Fukuda Y, Matsumoto I, Misaka T, Abe K.

Oral Oncol, 2009 Mar;45(3):e19-23. Epub 2008 Jul 11.
ページトップ